UBS Group’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $230K | Buy |
31,020
+18,228
| +142% | +$135K | ﹤0.01% | 5400 |
|
|
2025
Q1 | $110K | Buy |
12,792
+6,301
| +97% | +$54.2K | ﹤0.01% | 5714 |
|
|
2024
Q4 | $232K | Sell |
6,491
-12,450
| -66% | -$445K | ﹤0.01% | 5171 |
|
|
2024
Q3 | $895K | Buy |
18,941
+17,542
| +1,254% | +$829K | ﹤0.01% | 3677 |
|
|
2024
Q2 | $70.3K | Sell |
1,399
-10,188
| -88% | -$512K | ﹤0.01% | 5283 |
|
|
2024
Q1 | $1.3M | Buy |
11,587
+5,456
| +89% | +$611K | ﹤0.01% | 3356 |
|
|
2023
Q4 | $356K | Buy |
6,131
+3,853
| +169% | +$223K | ﹤0.01% | 4217 |
|
|
2023
Q3 | $72.3K | Sell |
2,278
-4,667
| -67% | -$148K | ﹤0.01% | 4938 |
|
|
2023
Q2 | $571K | Sell |
6,945
-471
| -6% | -$38.7K | ﹤0.01% | 3720 |
|
|
2023
Q1 | $762K | Sell |
7,416
-4,128
| -36% | -$424K | ﹤0.01% | 3394 |
|
|
2022
Q4 | $1.69M | Buy |
11,544
+10,492
| +997% | +$1.54M | ﹤0.01% | 2700 |
|
|
2022
Q3 | $178K | Buy |
1,052
+699
| +198% | +$118K | ﹤0.01% | 4171 |
|
|
2022
Q2 | $41K | Sell |
353
-252
| -42% | -$29.3K | ﹤0.01% | 5055 |
|
|
2022
Q1 | $60K | Sell |
605
-6,642
| -92% | -$659K | ﹤0.01% | 5296 |
|
|
2021
Q4 | $1.13M | Buy |
7,247
+3,718
| +105% | +$578K | ﹤0.01% | 3350 |
|
|
2021
Q3 | $832K | Buy |
3,529
+2,592
| +277% | +$611K | ﹤0.01% | 3385 |
|
|
2021
Q2 | $318K | Sell |
937
-2,546
| -73% | -$864K | ﹤0.01% | 4040 |
|
|
2021
Q1 | $1.41M | Buy |
3,483
+3,229
| +1,271% | +$1.31M | ﹤0.01% | 3052 |
|
|
2020
Q4 | $169K | Buy |
254
+136
| +115% | +$90.5K | ﹤0.01% | 4375 |
|
|
2020
Q3 | $55K | Buy |
118
+11
| +10% | +$5.13K | ﹤0.01% | 4733 |
|
|
2020
Q2 | $62K | Sell |
107
-897
| -89% | -$520K | ﹤0.01% | 4857 |
|
|
2020
Q1 | $146K | Sell |
1,004
-815
| -45% | -$119K | ﹤0.01% | 4125 |
|
|
2019
Q4 | $261K | Buy |
1,819
+679
| +60% | +$97.4K | ﹤0.01% | 4417 |
|
|
2019
Q3 | $45K | Buy |
1,140
+840
| +280% | +$33.2K | ﹤0.01% | 5312 |
|
|
2019
Q2 | $30K | Buy |
300
+240
| +400% | +$24K | ﹤0.01% | 5465 |
|
|
2019
Q1 | $8K | Sell |
60
-232
| -79% | -$30.9K | ﹤0.01% | 6106 |
|
|
2018
Q4 | $30K | Buy |
292
+159
| +120% | +$16.3K | ﹤0.01% | 5577 |
|
|
2018
Q3 | $33K | Buy |
133
+59
| +80% | +$14.6K | ﹤0.01% | 5565 |
|
|
2018
Q2 | $33K | Buy |
74
+9
| +14% | +$4.01K | ﹤0.01% | 5404 |
|
|
2018
Q1 | $26K | Buy |
65
+14
| +27% | +$5.6K | ﹤0.01% | 5349 |
|
|
2017
Q4 | $21K | Sell |
51
-13
| -20% | -$5.35K | ﹤0.01% | 5549 |
|
|
2017
Q3 | $28K | Sell |
64
-3
| -4% | -$1.31K | ﹤0.01% | 5313 |
|
|
2017
Q2 | $24K | Buy |
+67
| New | +$24K | ﹤0.01% | 5229 |
|